Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial

Sang Min Yoon, So Yeon Kim, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Jihyun An, Jinhong Jung, Jong Hoon Kim, Han Chu Lee

Clin Mol Hepatol. 2020;26(4):506-515. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0038

View: 6831 Download: 199 Web of Science: 47 Crossref: 50

Review

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clin Mol Hepatol. 2020;26(4):411-429. Published online August 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0049

View: 14933 Download: 1,443 Web of Science: 66 Crossref: 66

Novel biomarkers for the management of chronic hepatitis B

Takako Inoue, Yasuhito Tanaka

Clin Mol Hepatol. 2020;26(3):261-279. Published online June 15, 2020

DOI: https://doi.org/10.3350/cmh.2020.0032

View: 15253 Download: 705 Web of Science: 78 Crossref: 81

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

Chung-Feng Huang, Ming-Lung Yu

Clin Mol Hepatol. 2020;26(3):251-260. Published online March 19, 2020

DOI: https://doi.org/10.3350/cmh.2020.0018

View: 14632 Download: 390 Web of Science: 39 Crossref: 42

Original Article

The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?

Sujata Lall, Pragya Agarwala, Guresh Kumar, Manoj Kumar Sharma, Ekta Gupta

Clin Mol Hepatol. 2020;26(2):187-195. Published online April 7, 2020

DOI: https://doi.org/10.3350/cmh.2019.0060

View: 10860 Download: 339 Web of Science: 12 Crossref: 12

Review

Switching to systemic therapy after locoregional treatment failure: Definition and best timing

Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato

Clin Mol Hepatol. 2020;26(2):155-162. Published online January 15, 2020

DOI: https://doi.org/10.3350/cmh.2019.0021n

View: 10211 Download: 414 Web of Science: 43 Crossref: 40

Drug induced liver injury: East versus West – a systematic review and meta-analysis

En Xian Sarah Low, Qishi Zheng, Edwin Chan, Seng Gee Lim

Clin Mol Hepatol. 2020;26(2):142-154. Published online December 10, 2019

DOI: https://doi.org/10.3350/cmh.2019.1003

View: 9436 Download: 538 Web of Science: 24 Crossref: 27

The fibrogenic process and the unleashing of acute-on-chronic liver failure

Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Natalia Nuño-Lámbarri

Clin Mol Hepatol. 2020;26(1):7-15. Published online June 14, 2019

DOI: https://doi.org/10.3350/cmh.2019.0011

View: 11679 Download: 370 Web of Science: 9 Crossref: 11

Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation

Jongwook Oh, Jong Man Kim

Clin Mol Hepatol. 2020;26(1):1-6. Published online March 26, 2019

DOI: https://doi.org/10.3350/cmh.2019.0023

View: 15873 Download: 618 Web of Science: 23 Crossref: 25

Original Article

Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand

Ratchapong Laiwatthanapaisan, Pimsiri Sripongpun, Naichaya Chamroonkul, Arunee Dechaphunkul, Chirawadee Sathitruangsak, Siwat Sakdejayont, Chanon Kongkamol, Teerha Piratvisuth

Clin Mol Hepatol. 2019;25(4):366-373. Published online July 17, 2019

DOI: https://doi.org/10.3350/cmh.2018.0111

View: 5288 Download: 111 Web of Science: 3 Crossref: 5

Review

Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?

Keun Soo Ahn, Koo Jeong Kang

Clin Mol Hepatol. 2019;25(4):354-359. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0096

View: 7855 Download: 361 Web of Science: 42 Crossref: 41

Original Article

Evaluation of bioenergetic and mitochondrial function in liver transplantation

Rui Miguel Martins, João Soeiro Teodoro, Emanuel Furtado, Anabela Pinto Rolo, Carlos Marques Palmeira, José Guilherme Tralhão

Clin Mol Hepatol. 2019;25(2):190-198. Published online March 22, 2019

DOI: https://doi.org/10.3350/cmh.2018.0087

View: 7113 Download: 166 Web of Science: 7 Crossref: 6

Review

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection

Nadia Marascio, Angela Quirino, Giorgio Settimo Barreca, Luisa Galati, Chiara Costa, Vincenzo Pisani, Maria Mazzitelli, Giovanni Matera, Maria Carla Liberto, Alfredo Focà, Carlo Torti

Clin Mol Hepatol. 2019;25(1):30-36. Published online January 23, 2019

DOI: https://doi.org/10.3350/cmh.2018.0061

View: 7840 Download: 153 Web of Science: 14 Crossref: 17

Case Report

Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B

Hyeji Kim, Jung Hyun Kwon, Yong Hee Kim, Soon Woo Nam, Jong Yul Lee, Jeong Won Jang

Clin Mol Hepatol. 2018;24(4):430-435. Published online November 27, 2017

DOI: https://doi.org/10.3350/cmh.2017.0016

View: 8387 Download: 236 Web of Science: 2 Crossref: 2

Original Article

Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases

San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón

Clin Mol Hepatol. 2018;24(4):384-391. Published online July 4, 2018

DOI: https://doi.org/10.3350/cmh.2018.0004

View: 7939 Download: 199 Web of Science: 11 Crossref: 10

Review

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals

Soon Young Ko, Won Hyeok Choe

Clin Mol Hepatol. 2018;24(4):351-357. Published online March 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0063

View: 9962 Download: 350 Web of Science: 4 Crossref: 1

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL

Jong Eun Yeon

Clin Mol Hepatol. 2018;24(3):278-293. Published online May 2, 2018

DOI: https://doi.org/10.3350/cmh.2018.1002

View: 10437 Download: 237 Web of Science: 13 Crossref: 12

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

Clin Mol Hepatol. 2018;24(3):169-229. Published online August 10, 2018

DOI: https://doi.org/10.3350/cmh.2018.1004

View: 14580 Download: 222 Web of Science: 20 Crossref: 27

Original Article

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2018;24(2):144-150. Published online January 16, 2018

DOI: https://doi.org/10.3350/cmh.2017.0041

View: 9165 Download: 173 Web of Science: 12 Crossref: 11

Editorial

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion

Jin Wook Chung

Clin Mol Hepatol. 2018;24(2):135-136. Published online February 22, 2018

DOI: https://doi.org/10.3350/cmh.2018.1001

View: 7302 Download: 152

Review

Microbiota, a key player in alcoholic liver disease

Anne-Marie Cassard, Dragos Ciocan

Clin Mol Hepatol. 2018;24(2):100-107. Published online December 22, 2017

DOI: https://doi.org/10.3350/cmh.2017.0067

View: 11940 Download: 525 Web of Science: 63 Crossref: 65

Original Article

Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B

Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh

Clin Mol Hepatol. 2017;23(4):331-339. Published online September 26, 2017

DOI: https://doi.org/10.3350/cmh.2016.0040

View: 8298 Download: 218 Web of Science: 14 Crossref: 10

Editorial

Use of sofosbuvir in chronic kidney disease: Is it necessary?

Tae Seop Lim, Sang Hoon Ahn

Clin Mol Hepatol. 2017;23(4):308-310. Published online September 26, 2017

DOI: https://doi.org/10.3350/cmh.2017.0109

View: 5946 Download: 118 Web of Science: 4 Crossref: 6

Review

Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification

Dong Ho Lee

Clin Mol Hepatol. 2017;23(4):290-301. Published online October 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0042

View: 21446 Download: 481 Web of Science: 97 Crossref: 94

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 11203 Download: 361 Web of Science: 37 Crossref: 36

Case Report

A case of Alagille syndrome presenting with chronic cholestasis in an adult

Jihye Kim, Bumhee Yang, Namyoung Paik, Yon Ho Choe, Yong-Han Paik

Clin Mol Hepatol. 2017;23(3):260-264. Published online July 7, 2017

DOI: https://doi.org/10.3350/cmh.2016.0057

View: 8099 Download: 139 Web of Science: 9 Crossref: 8

Original Article

Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?

Linda L. Wong, Ruel J. Reyes, Sandi A. Kwee, Brenda Y. Hernandez, Sumodh C. Kalathil, Naoky C. Tsai

Clin Mol Hepatol. 2017;23(3):239-248. Published online July 14, 2017

DOI: https://doi.org/10.3350/cmh.2017.0008

View: 7974 Download: 144 Web of Science: 33 Crossref: 35

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion

Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0088

View: 9006 Download: 240 Web of Science: 32 Crossref: 28

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study

Kwang Il Seo, Byung Chul Yun, Weiquan James Li, Sang Uk Lee, Byung Hoon Han, Eun Taek Park

Clin Mol Hepatol. 2017;23(1):74-79. Published online March 3, 2017

DOI: https://doi.org/10.3350/cmh.2016.0052

View: 7675 Download: 147 Web of Science: 2 Crossref: 2

Editorial

Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension?

Beom Kyung Kim

Clin Mol Hepatol. 2017;23(1):27-30. Published online March 24, 2017

DOI: https://doi.org/10.3350/cmh.2017.0101

View: 7103 Download: 114 Web of Science: 3 Crossref: 3

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search